Surrogate end points for prostate cancer: what is prostate-specific antigen telling us?

Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: A Randomized Clinical Trial.

JAMA·2026

Influence of Adverse Pathologic Features on Potential Benefit of Hormone Therapy Use with Postoperative Radiotherapy in Recurrent Prostate Cancer: An Individual Patient Data Meta-analysis.

European urology·2026

Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the Reach of Precision Oncology.

JCO precision oncology·2026

Single-cell transcriptomic analysis reveals tumor-immune determinants of lymph node colonization and progression in thyroid cancer.

Science advances·2026

Implications for Radiation Microboosting Based on Pathology Correlations With Prostate-Specific Membrane Antigen and Multiparametric Magnetic Resonance Imaging Findings.

Advances in radiation oncology·2026

Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysis.

Lancet (London, England)·2026

Endocrine therapy in early-stage estrogen Receptor-Low breast cancer: a systematic review and Meta-Analysis.

Journal of the National Cancer Institute·2026

Development and validation of a predictive model of aromatase inhibitor-induced arthralgia among patients with early breast cancer.

Journal of the National Cancer Institute·2026

Leiomyosarcoma survival across anatomical sites identifies high- and low-risk patient groups to inform clinical trial design.

Journal of the National Cancer Institute·2026

Redefining reach: inclusivity gaps in UK phase 3 head and neck trial protocols over the last decade.

Journal of the National Cancer Institute·2026

Prospective multicenter validation of a Urine-Based multiplex assay for risk stratification of patients presenting with gross hematuria.

Journal of the National Cancer Institute·2026

Cervical human papillomavirus status among women with chronic inflammatory rheumatic diseases: matched cohort study.

Journal of the National Cancer Institute·2026

AI-derived Histopathological Signatures Are Associated With Response to Mepolizumab in Chronic Rhinosinusitis With Nasal Polyps.

American journal of rhinology & allergy·2026

Risk factors for carfilzomib-related cardiovascular adverse events in Chinese patients with multiple myeloma: A real-world retrospective cohort study.

The Journal of international medical research·2026

HSPA8 globally modulates transcriptome profile and PI3K/AKT signaling pathway to facilitate malignant progression phenotypes of triple-negative breast cancer.

Science progress·2026

Combining Statistical Modeling and Machine Learning for Prognostic Feature Selection in Cervical Cancer: A Retrospective Study Based on SEER 2004 to 2015 Data.

American journal of clinical oncology·2026

Prognostic value of inflammation-immunity-nutrition score in cancer patients: a meta-analysis.

Annals of medicine·2026

ASSOCIATION OF SYNOVITIS ACTIVITY MEASURED BY SYNOVIAL TISSUE VOLUME (STV) AND DYNAMIC CONTRAST-ENHANCED (DCE)-MRI IN PATIENTS WITH INFLAMMATORY KNEE OSTEOARTHRITIS.

Osteoarthritis imaging·2026

Related Experiment Videos

Surrogate end points for prostate cancer: what is prostate-specific antigen telling us?

Related Concept Videos

Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: A Randomized Clinical Trial.

Influence of Adverse Pathologic Features on Potential Benefit of Hormone Therapy Use with Postoperative Radiotherapy in Recurrent Prostate Cancer: An Individual Patient Data Meta-analysis.

Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the Reach of Precision Oncology.

Single-cell transcriptomic analysis reveals tumor-immune determinants of lymph node colonization and progression in thyroid cancer.

Implications for Radiation Microboosting Based on Pathology Correlations With Prostate-Specific Membrane Antigen and Multiparametric Magnetic Resonance Imaging Findings.

Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysis.

Endocrine therapy in early-stage estrogen Receptor-Low breast cancer: a systematic review and Meta-Analysis.

Development and validation of a predictive model of aromatase inhibitor-induced arthralgia among patients with early breast cancer.

Leiomyosarcoma survival across anatomical sites identifies high- and low-risk patient groups to inform clinical trial design.

Redefining reach: inclusivity gaps in UK phase 3 head and neck trial protocols over the last decade.

Prospective multicenter validation of a Urine-Based multiplex assay for risk stratification of patients presenting with gross hematuria.

Cervical human papillomavirus status among women with chronic inflammatory rheumatic diseases: matched cohort study.

AI-derived Histopathological Signatures Are Associated With Response to Mepolizumab in Chronic Rhinosinusitis With Nasal Polyps.

Risk factors for carfilzomib-related cardiovascular adverse events in Chinese patients with multiple myeloma: A real-world retrospective cohort study.

HSPA8 globally modulates transcriptome profile and PI3K/AKT signaling pathway to facilitate malignant progression phenotypes of triple-negative breast cancer.

Combining Statistical Modeling and Machine Learning for Prognostic Feature Selection in Cervical Cancer: A Retrospective Study Based on SEER 2004 to 2015 Data.

Prognostic value of inflammation-immunity-nutrition score in cancer patients: a meta-analysis.

ASSOCIATION OF SYNOVITIS ACTIVITY MEASURED BY SYNOVIAL TISSUE VOLUME (STV) AND DYNAMIC CONTRAST-ENHANCED (DCE)-MRI IN PATIENTS WITH INFLAMMATORY KNEE OSTEOARTHRITIS.

Related Experiment Videos

Surrogate end points for prostate cancer: what is prostate-specific antigen telling us?

Related Concept Videos

Related Articles